Skin
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials
FEATURING
Douglas Johnson
- 18 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Metastatic Melanoma Highlights
FEATURING
Christian Blank
- 44 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CFT1946, a Novel BRAF V600X Degrader, in Preliminary Results in BRAF V600 Mutant Solid Tumors
FEATURING
Maria Vieito
- 7 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Nivo + Ipi ± ASTX727 in Anti-PD-1 Resistant Metastatic Melanoma - NIBIT-ML1 Ph2 Study
FEATURING
Anna Maria Di Giacomo
- 41 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Survival Impact of Adjuvant Treatment in Stage III Melanoma
FEATURING
Hildur Helgadottir
- 43 views
- September 20, 2024